Health
SARS-CoV-2 evolves antibody resistance in immunocompromised patient – News-Medical.Net
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found…
Researchers in the United States who tracked the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient found that convalescent plasma therapy was associated with the emergence of viral variants that were less susceptible to neutralizing antibodies.
The SARS-CoV-2 virus is the agent responsible for the coronavirus 2019 (COVID-19) pandemic that continues to pose a significant threat to global public health and the worldwide economy.
The team’s analysis…
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General13 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips